Skip to main content

Table 2 Clinical details and RT-PCR positivity data.

From: Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR

 

Stage

T

N

ER

PR

Grade

LVI

TACSTD1

EPHB4

ELF3

EGFR

MGB1

1

in situ

Tis

-

x

x

ND

-

-

-

-

-

-

2

in situ

Tis

-

+

+

ND

-

-

-

-

-

-

3

in situ

Tis

-

-

-

ND

-

-

-

-

-

-

4

in situ

Tis

-

+

+

ND

-

-

-

-

-

-

5

in situ

Tis

-

x

x

ND

-

-

-

-

-

-

6

in situ

Tis

-

x

x

ND

-

-

-

+

-

-

7

in situ

Tis

-

x

x

ND

-

+

+

+

+

-

8

In situ

Tis

x

+

+

2

-

-

-

-

-

-

9

I

T1

-

+

+

1

-

-

-

-

-

-

10

I

T1

-

+

-

1

-

-

-

-

-

-

11

I

T1

-

+

+

1

-

-

-

-

-

-

12

I

T1

-

+

+

1

-

-

-

-

-

-

13

I

T1

-

+

+

1

-

-

-

-

-

-

14

I

T1

-

+

+

1

-

-

-

-

-

-

15

I

T1

-

+

+

1

 

-

-

-

-

-

16

I

T1

-

+

+

1

-

+

-

-

-

-

17

I

T1

-

+

+

1

-

+

+

-

+

-

18

I

T1

-

+

+

2

-

-

-

-

-

-

19

I

T1

-

+

+

2

-

-

-

-

-

-

20

I

T1

-

-

+

2

-

-

-

-

-

-

21

I

T1

-

+

+

2

-

-

-

-

-

-

22

I

T1

-

-

-

3

-

+

+

-

-

-

23

I

T1

-

+

+

3

-

-

-

-

-

-

24

I

T1

-

+

+

3

+

+

+

+

-

-

25

I

T1

-

-

+

ND

-

-

-

-

-

-

26

IIa

T1

+

+

-

1

-

+

+

+

+

+

27

IIa

T1

+

+

+

1

-

-

-

-

-

-

28

IIa

T1

+

+

+

2

-

+

+

+

+

+

29

IIa

T1

+

+

+

2

-

+

+

+

+

+

30

IIa

T1

+

+

+

2

+

+

+

+

+

+

31

IIa

T1

+

x

x

2

+

-

-

-

-

-

32

IIa

T1

+

+

+

2

-

-

-

-

-

-

33

IIa

T1

+

-

+

3

-

+

+

+

+

-

34

IIa

T2

-

x

x

1

-

-

-

-

-

-

35

IIa

T2

-

+

+

1

-

-

-

-

-

-

36

IIa

T2

-

+

+

1

-

-

-

-

-

-

37

IIa

T2

-

+

+

1

-

-

-

-

-

-

38

IIa

T2

-

+

+

1

+

+

+

+

-

-

39

IIa

T2

-

+

+

1

+

+

+

+

+

-

40

IIa

T2

-

+

+

2

-

-

-

-

-

-

41

IIa

T2

-

+

+

2

-

-

-

-

-

-

42

IIa

T2

-

+

+

2

+

-

-

-

-

-

43

IIa

T2

-

+

+

2

-

-

-

-

-

-

44

IIa

T2

-

+

+

2

+

-

-

-

-

-

45

IIa

T2

-

-

-

3

-

-

-

-

-

-

46

IIa

T1

-

+

+

2

-

-

-

-

-

-

47

IIb

T2

+

+

+

1

-

+

+

+

+

-

48

IIb

T2

+

x

x

2

+

+

+

+

+

+

49

IIb

T2

+

+

+

3

+

+

+

+

+

+

50

IIb

T2

+

+

+

3

-

+

+

+

+

+

51

IIb

T2

+

+

-

3

+

+

+

+

+

-

52

IIb

T2

+

-

-

3

+

-

-

-

-

-

53

IIb

T3

-

-

-

3

+

+

+

+

+

-

54

IIb

T1

x

-

-

2

+

+

+

+

+

+

55

IIb

T2

x

-

-

3

+

+

+

+

+

-

56

IIIa

T3

+

x

x

2

-

+

+

+

+

-

  1. Stage, tumour size (T), nodal status (N), estrogen receptor status (ER) and progesterone receptor status (PR), lymphovascular invasion (LVI), tumour grade, and positive or negative expression of the 5 RT-PCR markers are shown for the 56 breast cancer patients. ND denotes no data. x denotes unknown.